Health Canada inspection
Prestilux Inc.: Health Canada inspection of May 15, 2026
Health Canada · GMP · rating C
Key facts
| Establishment | Prestilux Inc. |
|---|---|
| City | Laval |
| Province | Quebec |
| Country | Canada |
| Program | GMP |
| Start date | May 14, 2026 |
| End date | May 15, 2026 |
| Rating | C |
| Rating description | Compliant |
| Licence number | 101156 |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- Yes Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.